Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Weide Benjamin; Martens Alexander; Hassel Jessica C.; Berking Carola; Postow Michael A.; Bisschop Kees; Simeone Ester; Mangana Johanna; Schilling Bastian; Di Giacomo Anna Maria; Brenner Nicole; Kaehler Katharina; Heinzerling Lucie; Gutzmer Ralf; Bender Armin; Gebhardt Christoffer; Romano Emanuela; Meier Friedegund; Martus Peter; Maio Michele; Blank Christian; Schadendorf Dirk; Dummer Reinhard; Ascierto Paolo A.; Hospers Geke; Garbe Claus; Wolchok Jedd D.

首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

【24h】

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

机译：派姆单抗治疗的黑色素瘤患者预后的基线生物标志物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: Biomarkers for outcome after immune-checkpoint blockade are strongly needed as these may influence individual treatment selection or sequence. We aimed to identify baseline factors associated with overall survival (OS) after pembrolizumab treatment in melanoma patients.

机译：目的：强烈需要用于免疫检查点阻断后结果的生物标志物，因为这些标志物可能会影响个别治疗的选择或顺序。我们的目标是确定与黑色素瘤患者接受pembrolizumab治疗后的总体生存（OS）相关的基线因素。

著录项

来源
《Clinical cancer research: an official journal of the American Association for Cancer Research》 |2016年第22期|共10页
作者
Weide Benjamin; Martens Alexander; Hassel Jessica C.; Berking Carola; Postow Michael A.; Bisschop Kees; Simeone Ester; Mangana Johanna; Schilling Bastian; Di Giacomo Anna Maria; Brenner Nicole; Kaehler Katharina; Heinzerling Lucie; Gutzmer Ralf; Bender Armin; Gebhardt Christoffer; Romano Emanuela; Meier Friedegund; Martus Peter; Maio Michele; Blank Christian; Schadendorf Dirk; Dummer Reinhard; Ascierto Paolo A.; Hospers Geke; Garbe Claus; Wolchok Jedd D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab [J] . Weide Benjamin, Martens Alexander, Hassel Jessica C., Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第22期

机译：派姆单抗治疗的黑色素瘤患者预后的基线生物标志物
2. Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab [J] . Martens Alexander, Wistuba-Hamprecht Kilian, Foppen Marnix Geukes, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第12期

机译：依匹莫单抗治疗的晚期黑素瘤患者的临床结局与基线外周血生物标志物
3. Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab [J] . Durot Carole, Mule Sebastien, Soyer Philippe, European radiology . 2019,第6期

机译：转移性黑色素瘤：预处理对比增强CT纹理参数作为用PEMBROLIZUAB治疗的患者存活的预测生物标志物
4. Dynamic Infrared Imaging of the Skin Reaction in Melanoma Patients Treated with Boron Neutron Capture Therapy [C] . Gustavo Santa Cruza, Sara González, José Bertotti, Congress of the International Radiation Protection Association;IRPA 12 . 2010

机译：硼中子俘获疗法治疗黑素瘤患者皮肤反应的动态红外成像
5. Serial Changes in Serum and Fecal Biomarkers Levels in Pediatric Patients with IBD Treated with Remicade [D] . Zapata, Juliana Maria. 2018

机译：灌注治疗IBD患者血清和粪便生物标志物水平的连续变化
6. A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab [O] . Gil Awada, Yanina Jansen, Julia Katharina Schwarze, 2021

机译：综合分析与Pembrolizuab治疗的先期黑色素瘤患者结果相关的基线临床特征和生物标志物
7. Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab [O] . Weide, Benjamin, Martens, Alexander, Hassel, Jessica C., 2016

机译：Pembrolizumab治疗的黑色素瘤患者结果的基线生物标志物

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

摘要

著录项

相似文献

相关主题

期刊订阅